GlaxoSmithKline to invest 200 million pounds in UK manufacturing sites - FirstWord Pharma
Coincidence? You decide....
GlaxoSmithKline is to invest a total of approximately 200 million pounds ($328 million) in the UK to support its drug pipeline and create a centre for pharmaceutical manufacturing innovation, the company reported Wednesday.
[....]
....The construction of the plant at Ulverston, Cumbria was part of commitments from GlaxoSmithKline announced in 2012 to invest more than 500 million pounds ($820 million) in its UK manufacturing sites. The company also recently said that it would invest 25 million pounds ($41 million) to expand operations at its Montrose site to support the delivery of its drug pipeline.
Coincidence? You decide....